## Core Concept
The question revolves around the choice of antibiotic for treating *Haemophilus influenzae* meningitis, specifically comparing cefotaxime to ampicillin. This involves understanding the antimicrobial spectrum, resistance patterns, and the pharmacodynamics of these antibiotics.

## Why the Correct Answer is Right
Cefotaxime, a third-generation cephalosporin, is preferred over ampicillin for treating *H. influenzae* meningitis primarily because of its effectiveness against beta-lactamase-producing strains of *H. influenzae*. *H. influenzae* can produce beta-lactamase enzymes that confer resistance to ampicillin and other penicillins. Cefotaxime, being a beta-lactamase-stable cephalosporin, maintains its activity against these resistant strains, making it a more reliable choice for empirical treatment of bacterial meningitis, especially when the causative organism is not yet identified.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is blank and does not provide any information to evaluate.
- **Option B:** This option is also blank and lacks any relevant details for assessment.
- **Option C:** Similarly, this option does not contain any information that could be considered.
- **Option D:** This option is blank as well.

## Clinical Pearl / High-Yield Fact
A crucial point to remember is that the introduction of *H. influenzae* type b (Hib) vaccine has significantly reduced the incidence of *H. influenzae* infections, including meningitis. However, in regions with low vaccination rates or in cases where the vaccine does not match the infecting strain, *H. influenzae* remains a concern. The choice of antibiotics like cefotaxime over ampicillin is critical in severe infections like meningitis, where initial empirical therapy can be life-saving.

## Correct Answer: B.